Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Technically Speaking
|
March 2011
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
TECHNICALLY SPEAKING
Tdap Recommendations Broadened
Published March 2011
With pertussis sweeping the nation, the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) recently expanded its recommendations for the use of Tdap vaccine. The newly published recommendations include the following points:
Interval between Td and Tdap - Tdap can be administered regardless of the interval since the last Td vaccine was given (i.e., no waiting period is needed between a dose of Td and Tdap).
Catch-up vaccination for 7- to 10-year-olds - Children ages 7 through 10 years who did not complete a primary series of pertussis-containing vaccine (DTaP) should receive a single dose of Tdap as part of their catch-up schedule.
11- to 64-year-olds - All adolescents and adults ages 11 through 64 years who have not received a dose of Tdap or whose vaccination status is unknown should receive a single dose of Tdap as soon as feasible.
Older than 65 and in contact with an infant - Adults age 65 years and older who have not previously received Tdap, and who have or who anticipate having close contact with an infant (e.g., grandparents, other relatives, child care providers, and healthcare personnel), should receive a single dose of Tdap to reduce the likelihood of transmitting pertussis to the infant .
All others 65 and older - Other adults age 65 years and older who have not previously received Tdap may be given a single dose of Tdap in place of Td.
Though giving Tdap vaccine to people 7 through 9 years and 65 years and older is off-label, CDC recommends use of Tdap in these age groups regardless.
Read the updated Tdap recommendations from CDC as published in the MMWR in January
In a further effort to protect patients and healthcare workers from pertussis, ACIP voted in February 2011, to expand its recommendation for the use of Tdap to include all healthcare workers regardless of age, as soon as feasible. This includes healthcare workers age 65 years and older. In addition, ACIP voted to recommend that healthcare facilities cover the cost of Tdap vaccine for its healthcare workers. These recommendations are likely to be published later in 2011; healthcare settings may want to start planning now.
2011 ISSUES >> view all
DECEMBER 2011
"Catching-up" Kids – and Don’t Forget the Supplemental Dose of PCV13
NOVEMBER 2011
Which Children Need Two Doses of Influenza Vaccine for the 2011-2012 Season?
OCTOBER 2011
Screening Patients for Contraindications to Vaccination
SEPTEMBER 2011
Guidance for Busy Clinics on Prefilling Your Own Syringes
AUGUST 2011
Are Your New Patients Missing Their Immunization Records?
JULY 2011
CDC’s “General Recommendations on Immunization” – Make Sure You Have a Copy!
JUNE 2011
Standing Orders Can Help You Vaccinate Your Patients
APRIL 2011
2011 Immunization Schedules Now Available
MARCH 2011
Tdap Recommendations Broadened
FEBRUARY 2011
Using Vaccine Information Statements (VISs) Correctly
 
This page was reviewed on May 8, 2012
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.